FARINGOMED
the Trade name
of FARINGOMED
the International unlicensed name
is not present
the Dosage form
of the Tablet for resorption
the Structure
of One tablet contains
active agents: Phytolacca americana (Phytolacca) C24, Atropa belladonna (Belladonna) C30, Hepar sulfuris C12, Acidum silicicum (Silicea) C12.
excipients: izomalt, sodium saccharin, sodium cyclomate, citric acid anhydrous, magnesium stearate.
The description
of the Tablet of a ploskotsilindrichesky form with risky and a facet, from white till almost white color. On the flat party from risky the inscription MATERIA MEDICA is put, on other flat party the inscription FARINGOMED is put.
Pharmacotherapeutic group
Drugs for treatment of diseases of a throat.
The code of automatic telephone exchange R02A
the Pharmacological
Pharmacokinetics Due to properties the maintenance of midget doses of active ingredients in drug, is not possible to conduct pharmacokinetic researches.
The pharmacodynamics
Has soothing and anti-inflammatory effect. Reduces puffiness, reddening, feeling of irritation and sore throat, facilitates nasal breath, reduces a likelihood of development of complications from ENT organs.
Indications
as a part of complex therapy - treatment of inflammatory diseases of a throat.
The route of administration and doses
On reception hold one tablet in a mouth before full dissolution.
It is reasonable to begin administration of drug at emergence of the first symptoms of a disease.
The drug is taken according to the following scheme: the first 2 hours of treatment - on 1 tablet each hour, then on 1 tablet each 3-4 hours, but no more than 5 tablets a day.
Frequency and a single dose of administration of drug does not depend on age of the patient.
At preservation of the expressed symptoms of a disease within 24 hours from the moment of an initiation of treatment of drug it is necessary to see a doctor.
Side effects
- when using on the specified indications in the specified dosages of side effect it is not revealed so far
- reactions of the increased individual sensitivity to drug components are possible.
Contraindications
- the increased individual sensitivity to drug components
- children's age up to 6 years.
Medicinal interactions
of Cases of incompatibility with other medicines it is not registered so far.
The special
instructions Pregnancy and the period of a lactation
Safety of use of Faringomed at pregnancy and in the period of a lactation was not studied. In need of administration of drug it is necessary to consider a ratio risk/advantage.
Features of influence on ability to run motor transport or other potentially dangerous mechanisms.
Drug does not affect ability of control of motor transport and other potentially dangerous mechanisms.
Overdose
Symptoms: the dispepsichesky phenomena caused by the fillers which are a part of a dosage form are possible.
Treatment: symptomatic
the Form of release and packing
On 10 tablets in blister strip packaging from a film of polyvinylchloride and aluminum foil. On 1, 2 or 5 blister strip packagings together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
Storage conditions
In the place protected from light, at a temperature not above 25 °C.
To store out of children's reach!
3 years
not to apply a period of storage after an expiration date.
Prescription status
Without prescription
LLC NPF MATERIA MEDIKA HOLDING Producer Russian Federation, 127473, Moscow, 3rd Samotechny Lane, 9. Ph./fax: (495) 684-43-33
the Trade name
of FARINGOMED
the International unlicensed name
is not present
the Dosage form
of the Tablet for resorption
the Structure
of One tablet contains
active agents: Phytolacca americana (Phytolacca) C24, Atropa belladonna (Belladonna) C30, Hepar sulfuris C12, Acidum silicicum (Silicea) C12.
excipients: izomalt, sodium saccharin, sodium cyclomate, citric acid anhydrous, magnesium stearate.
The description
of the Tablet of a ploskotsilindrichesky form with risky and a facet, from white till almost white color. On the flat party from risky the inscription MATERIA MEDICA is put, on other flat party the inscription FARINGOMED is put.
Pharmacotherapeutic group
Drugs for treatment of diseases of a throat.
The code of automatic telephone exchange R02A
the Pharmacological
Pharmacokinetics Due to properties the maintenance of midget doses of active ingredients in drug, is not possible to conduct pharmacokinetic researches.
The pharmacodynamics
Has soothing and anti-inflammatory effect. Reduces puffiness, reddening, feeling of irritation and sore throat, facilitates nasal breath, reduces a likelihood of development of complications from ENT organs.
Indications
as a part of complex therapy - treatment of inflammatory diseases of a throat.
The route of administration and doses
On reception hold one tablet in a mouth before full dissolution.
It is reasonable to begin administration of drug at emergence of the first symptoms of a disease.
The drug is taken according to the following scheme: the first 2 hours of treatment - on 1 tablet each hour, then on 1 tablet each 3-4 hours, but no more than 5 tablets a day.
Frequency and a single dose of administration of drug does not depend on age of the patient.
At preservation of the expressed symptoms of a disease within 24 hours from the moment of an initiation of treatment of drug it is necessary to see a doctor.
Side effects
- when using on the specified indications in the specified dosages of side effect it is not revealed so far
- reactions of the increased individual sensitivity to drug components are possible.
Contraindications
- the increased individual sensitivity to drug components
- children's age up to 6 years.
Medicinal interactions
of Cases of incompatibility with other medicines it is not registered so far.
The special
instructions Pregnancy and the period of a lactation
Safety of use of Faringomed at pregnancy and in the period of a lactation was not studied. In need of administration of drug it is necessary to consider a ratio risk/advantage.
Features of influence on ability to run motor transport or other potentially dangerous mechanisms.
Drug does not affect ability of control of motor transport and other potentially dangerous mechanisms.
Overdose
Symptoms: the dispepsichesky phenomena caused by the fillers which are a part of a dosage form are possible.
Treatment: symptomatic
the Form of release and packing
On 10 tablets in blister strip packaging from a film of polyvinylchloride and aluminum foil. On 1, 2 or 5 blister strip packagings together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
Storage conditions
In the place protected from light, at a temperature not above 25 °C.
To store out of children's reach!
3 years
not to apply a period of storage after an expiration date.
Prescription status
Without prescription
LLC NPF MATERIA MEDIKA HOLDING Producer Russian Federation, 127473, Moscow, 3rd Samotechny Lane, 9. Ph./fax: (495) 684-43-33
Related Products
